TY - JOUR
T1 - The Australian living guidelines for the clinical care of people with COVID-19
T2 - What worked, what didn't and why, a mixed methods process evaluation
AU - Turner, Tari
AU - Elliott, Julian
AU - Tendal, Britta
AU - Vogel, Joshua P.
AU - Norris, Sarah
AU - Tate, Rhiannon
AU - Green, Sally
AU - the National COVID-19 Clinical Evidence Taskforce
AU - McGowan, Sharon
AU - Ballenden, Nicola
AU - Barrett, Terri Lee
AU - Beavis, Vanessa
AU - Saunders, James Beckford
AU - Buchanan, Tanya
AU - Buchanan-Grey, Marina
AU - Casey, Dawn
AU - Cowie, Marita
AU - Doyle, Joseph
AU - Frydenberg, Mark
AU - Gnjidic, Danijela
AU - Greenland, Rohan
AU - Griffin, Ken
AU - Groombridge, Stephan
AU - Hardy, Louise
AU - Hodak, Alison
AU - Holley, Anthony
AU - Jovanovska, Vase
AU - Knight, Sabina
AU - Michaels, Kristin
AU - Morley, Peter
AU - Morphet, Julia
AU - Nou, Suzi
AU - Russo, Phillip
AU - Sarson, Megan
AU - Young, Alan
AU - Morris-Donovan, Bronwyn
AU - Gurry, Sharon
AU - Hudson, Eloise
AU - Hurley, Shauna
AU - Primmer, Declan
AU - Timms, Samantha
AU - Whicker, Susan
AU - Mukherjee, Sutapa
AU - Agostino, Jason
AU - Booth, Karen
AU - Burr, Lucy
AU - Byers, Lyn
AU - Cameron, Peter
AU - Cooper, Megan
AU - Cheng, Allen
AU - Fowler, Peter
AU - Glanville, Allan
AU - Homer, Caroline
AU - Leder, Karin
AU - McGloughlin, Steve
AU - McMullan, Brendan
AU - McPhee, Ewen
AU - Mitchell, Brett
AU - Morgan, Mark
AU - Myles, Paul
AU - O’Donnell, Chris
AU - Parr, Michael
AU - Phillips, Jane
AU - Randall, Rebecca
AU - Varndell, Wayne
AU - Whyte, Ian
AU - William, Leeroy
AU - Brightwell, Richard
AU - Condon, Lynda
AU - Deshpande, Amrita
AU - Ehm, Adam
AU - Ferrie, Monica
AU - Muller, Joanne
AU - Pullin, Lara
AU - Robinson, Elizabeth
AU - Witt, Adele
AU - Larkins, Sarah
AU - Taylor, Georgina
AU - Burgess, Paul
AU - Burns, Penny
AU - Douglas, Kirsty
AU - Ewald, Ben
AU - Ewald, Dan
AU - Fornasier, Dianna
AU - Nelson, Carmel
AU - Peachey, Louis
AU - Peiris, David
AU - van Driel, Mieke
AU - Walters, Lucie
AU - Weaver, Ineke
AU - Hendel, Simon
AU - Shekar, Kiran
AU - Avard, Bronwyn
AU - Cairns, Kelly
AU - Gilroy, Nicky
AU - O’Sullivan, Robert
AU - Robinson, Owen
AU - Sharland, Chantal
AU - McCarthy, Sally
AU - Wark, Peter
AU - McGoughlin, Steve
AU - Nair, Priya
AU - Hodgson, Carol
AU - Ankravs, Melissa
AU - French, Craig
AU - Hansen, Kim
AU - Huckson, Sue
AU - Iredell, Jon
AU - Janerka, Carrie
AU - Jaspers, Rose
AU - Litton, Ed
AU - Macdonald, Stephen
AU - Peake, Sandra
AU - Seppelt, Ian
AU - Roach, Vijay
AU - Giles, Michelle
AU - Whitehead, Clare
AU - Burton, Wendy
AU - Downton, Teena
AU - Gleeson, Glenda
AU - Gordon, Adrienne
AU - Hunt, Jenny
AU - Kitschke, Jackie
AU - McDonnell, Nolan
AU - Middleton, Philippa
AU - Oats, Jeremy
AU - Bowen, Asha
AU - Tingay, David
AU - Vasilunas, Nan
AU - Anderson, Lorraine
AU - Best, James
AU - Craig, Simon
AU - Erickson, Simon
AU - Fancourt, Nick
AU - Goff, Zoy
AU - Kapuya, Vimbai
AU - Keyte, Catherine
AU - Malyon, Lorelle
AU - Wurzel, Danielle
AU - Agar, Meera
AU - Lindley, Richard
AU - Smallwood, Natasha
AU - Callary, Mandy
AU - Chapman, Michael
AU - Good, Philip
AU - Jenkin, Peter
AU - Morgan, Deidre
AU - Naganathan, Vasi
AU - Srikanth, Velandai
AU - Tuffin, Penny
AU - Whiting, Elizabeth
AU - Yates, Patsy
AU - Barber, Bridget
AU - Davies, Jane
AU - Davis, Josh
AU - Gwee, Amanda
AU - Matthews, Gail
AU - McMahon, James
AU - Peel, Trisha
AU - Raftery, Chris
AU - Rees, Megan
AU - Roberts, Jason
AU - Snelling, Tom
AU - Wibrow, Brad
AU - Baker, Ross
AU - Curnow, Jennifer
AU - Cutts, Briony
AU - Enjeti, Anoop
AU - Forbes, Andrew
AU - Ho, Prahlad
AU - Holyoak, Adam
AU - Liley, Helen
AU - McFadyen, James
AU - McQuilten, Zoe
AU - Merriman, Eileen
AU - Savoia, Helen
AU - Tan, Chee Wee
AU - Tran, Huyen
AU - Ward, Chris
AU - Williams, Katrina
AU - Ballard, Neil
AU - Bendall, Samantha
AU - Bhanderi, Neel
AU - Ellis, Dan
AU - Fairley, Craig
AU - Hoggard, Brett
AU - Cong, Minh Le
AU - Pearce, Andrew
AU - McDonald, Steve
AU - Fraile Navarro, David
AU - White, Heath
AU - Chakraborty, Samantha
AU - Cheyne, Saskia
AU - Callesen, Henriette
AU - Campbell, Sue
AU - Ring, Jenny
AU - Wilson, Agnes
AU - Millard, Tanya
AU - Murano, Melissa
AU - Henry, David
AU - Pearson, Sallie
AU - Boyle, Douglas
AU - Chidwick, Kendal
AU - Chapman, Wendy
AU - Pearce, Chris
AU - Bero, Lisa
AU - Grundy, Quinn
AU - Lexchin, Joel
AU - Mintzes, Barbara
PY - 2022/1/7
Y1 - 2022/1/7
N2 - Introduction: The Australian National COVID-19 Clinical Evidence Taskforce is producing living, evidence-based, national guidelines for treatment of people with COVID-19 which are updated each week. To continually improve the process and outputs of the Taskforce, and inform future living guideline development, we undertook a concurrent process evaluation examining Taskforce activities and experience of team members and stakeholders during the first 5 months of the project.Methods: The mixed-methods process evaluation consisted of activity and progress audits, an online survey of all Taskforce participants; and semi-structured interviews with key contributors. Data were collected through five, prospective 4-weekly timepoints (beginning first week of May 2020) and three, fortnightly retrospective timepoints (March 23, April 6 and 20). We collected and analysed quantitative and qualitative data.Results: An updated version of the guidelines was successfully published every week during the process evaluation. The Taskforce formed in March 2020, with a nominal start date of March 23. The first version of the guideline was published two weeks later and included 10 recommendations. By August 24, in the final round of the process evaluation, the team of 11 staff, working with seven guideline panels and over 200 health decision-makers, had developed 66 recommendations addressing 58 topics. The Taskforce website had received over 200,000 page views. Satisfaction with the work of the Taskforce remained very high (>90% extremely or somewhat satisfied) throughout. Several key strengths, challenges and methods questions for the work of the Taskforce were identified.Conclusions: In just over 5 months of activity, the National COVID-19 Clinical Evidence Taskforce published 20 weekly updates to the evidence-based national treatment guidelines for COVID-19. This process evaluation identified several factors that enabled this achievement (e.g. an extant skill base in evidence review and convening), along with challenges that needed to be overcome (e.g. managing workloads, structure and governance) and methods questions (pace of updating, and thresholds for inclusion of evidence) which may be useful considerations for other living guidelines projects. An impact evaluation is also being conducted separately to examine awareness, acceptance and use of the guidelines.
AB - Introduction: The Australian National COVID-19 Clinical Evidence Taskforce is producing living, evidence-based, national guidelines for treatment of people with COVID-19 which are updated each week. To continually improve the process and outputs of the Taskforce, and inform future living guideline development, we undertook a concurrent process evaluation examining Taskforce activities and experience of team members and stakeholders during the first 5 months of the project.Methods: The mixed-methods process evaluation consisted of activity and progress audits, an online survey of all Taskforce participants; and semi-structured interviews with key contributors. Data were collected through five, prospective 4-weekly timepoints (beginning first week of May 2020) and three, fortnightly retrospective timepoints (March 23, April 6 and 20). We collected and analysed quantitative and qualitative data.Results: An updated version of the guidelines was successfully published every week during the process evaluation. The Taskforce formed in March 2020, with a nominal start date of March 23. The first version of the guideline was published two weeks later and included 10 recommendations. By August 24, in the final round of the process evaluation, the team of 11 staff, working with seven guideline panels and over 200 health decision-makers, had developed 66 recommendations addressing 58 topics. The Taskforce website had received over 200,000 page views. Satisfaction with the work of the Taskforce remained very high (>90% extremely or somewhat satisfied) throughout. Several key strengths, challenges and methods questions for the work of the Taskforce were identified.Conclusions: In just over 5 months of activity, the National COVID-19 Clinical Evidence Taskforce published 20 weekly updates to the evidence-based national treatment guidelines for COVID-19. This process evaluation identified several factors that enabled this achievement (e.g. an extant skill base in evidence review and convening), along with challenges that needed to be overcome (e.g. managing workloads, structure and governance) and methods questions (pace of updating, and thresholds for inclusion of evidence) which may be useful considerations for other living guidelines projects. An impact evaluation is also being conducted separately to examine awareness, acceptance and use of the guidelines.
KW - Australian National COVID-19 Clinical Evidence Taskforce
KW - COVID-19
KW - process evaluation
KW - mixed methods evaluation
KW - treatment guidelines
UR - http://www.scopus.com/inward/record.url?scp=85122929850&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0261479
DO - 10.1371/journal.pone.0261479
M3 - Article
SN - 1932-6203
VL - 17
JO - PLoS One
JF - PLoS One
IS - 1
M1 - e0261479
ER -